Search in:

Advanced search

Leukemia & Lymphoma Volume 59, 2018 - Issue 9

Submit an article Journal homepage

347

Views

CrossRef citations to date

Altmetric

Letter to the Editor

Chronic myelomonocytic leukemia with central nervous system involvement

Michelle HannonSidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA;

Lindsay WildeSidney Kimmel Cancer Center of Thomas Jefferson University Hospital, Philadelphia, PA, USA; Correspondence[email protected]

Nneamaka NwaoduahDepartment of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA, USA

Margaret KasnerSidney Kimmel Cancer Center of Thomas Jefferson University Hospital, Philadelphia, PA, USA;

Pages 2267-2268 | Received 30 Oct 2017, Accepted 22 Dec 2017, Published online: 11 Jan 2018

Cite this article
https://doi.org/10.1080/10428194.2017.1422866
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Reprints & Permissions

References

Guru Murthy GS, Dhakal I, Mehta P. Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States. Leuk Lymphoma. 2017;58:1648–1654.
PubMed Web of Science ®Google Scholar
Zandberg DP, Huang T-Y, Ke X, et al. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults. Haematologica. 2013;98:584–590.
PubMed Web of Science ®Google Scholar
Alfonso A, Montalban-Bravo G, Garcia-Manero G. Current management of patients with chronic myelomonocytic leukemia. Curr Opin Oncol. 2017;29:79–87.
PubMed Web of Science ®Google Scholar
Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management. Am J Hematol. 2016;91:631–642.
PubMed Web of Science ®Google Scholar
Solary E, Itzykson R. How I treat chronic myelomonocytic leukemia. Blood. 2017;130:126–136.
PubMed Web of Science ®Google Scholar
Muramatsu H, Makishima H, Maciejewski JP. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions. Semin Oncol. 2012;39:67–73.
PubMed Web of Science ®Google Scholar
Such E, Cervera J, Costa D, et al. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica. 2011; 96:375–383.
PubMed Web of Science ®Google Scholar
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
PubMed Web of Science ®Google Scholar
Deininger MWN, Tyner JW, Solary E. Turning the tide in myelodysplastic/myeloproliferative neoplasms. Nat Rev Cancer. 2017;17:425.
PubMed Web of Science ®Google Scholar
de Witte T, Bowen D, Robin M, et al. Use of hematopoietic cell transplantation for patients with myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood. 2017;129:1753–1762.
PubMed Web of Science ®Google Scholar
Aoyama K, Ishikura H, Tsumura H, et al. Meningeal involvement of chronic myelomonocytic leukemia. J Neurol. 2003; 250:993–994.
PubMed Web of Science ®Google Scholar
Slobodanka Ostojic IMR. Meningeal infiltration of chronic myelomonocytic leukemia. J Leuk. 2014;2:147.
Google Scholar
Wilson DB, Michalski JM, Grossman WJ, et al. Isolated CNS relapse following stem cell transplantation for juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol. 2003;25: 910–913.
PubMed Web of Science ®Google Scholar
Sakashita K, Matsuda K, Koike K. Diagnosis and treatment of juvenile myelomonocytic leukemia. Pediatr Int. 2016;58: 681–690.
PubMed Web of Science ®Google Scholar
Kekre N, Ho VT. Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia. Am J Hematol. 2016;91:123–130.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Chronic myelomonocytic leukemia with central nervous system involvement

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Chronic myelomonocytic leukemia with central nervous system involvement

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date